Acorda Therapeutics, Inc. (NASDAQ:ACOR) Reported Basic Consolidated EPS Of $0.2619 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Acorda Therapeutics, Inc. (NASDAQ:ACOR) for the period ended 2015-12-31 was $0.2619. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $0.2619.

EPS from continuing operations

Coming to basic EPS from continuing operations, Acorda Therapeutics, Inc. (NASDAQ:ACOR) reported $0.2619 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $0.2619.

EPS contribution from parent

For the annual period ended 2015-12-31, Acorda Therapeutics, Inc. (NASDAQ:ACOR) received basic EPS of $0.2619 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $0.2619.

Basic net EPS

For the annual period ended 2015-12-31, Acorda Therapeutics, Inc. (NASDAQ:ACOR) reported basic net EPS of $0.26. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $0.26.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $0.2535. For the quarter ended 2015-12-31, consolidated diluted EPS was $0.2535.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $0.2535 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $0.2535.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $0.25. For the quarterly period ended 2015-12-31, net diluted EPS was $0.25.

Diluted EPS from parent

From the parent company, Acorda Therapeutics, Inc. (NASDAQ:ACOR) received diluted EPS of $0.2535 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $0.2535.

Acorda Therapeutics, Inc. (NASDAQ:ACOR) posted net basic EPS reading of $0.26 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $0.26 was for the quarter ended 2015-12-31.

Net diluted EPS for Acorda Therapeutics, Inc. (NASDAQ:ACOR) for the annual period ended 2015-12-31 was $0.25. The company also reported net diluted EPS reading of $0.25 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 42.23 while for the quarter ended 2015-12-31 is 42.23.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 43.621 while for the quarter ended 2015-12-31 is 43.621.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 10 times, 1 visits today)